aTyr Pharma Inc. (ATYR): H.C. Wainwright sees 775% price potential - Treatment of inflammatory lung diseases will gain importance

aTyr Pharma Inc. (ATYR) is a biotechnology company that leverages evolutionary intelligence to translate the biology of tRNA synthetases into innovative therapies for fibrosis and inflammation. The tRNA synthetase platform of aTyr Pharma is based on a unique biological mechanism originally associated with the production of proteins in cells. In our cells, there are what are called tRNA synthetases—enzymes that play a crucial role in protein production. Researchers have discovered, however, that these enzymes are not only important for protein...